Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi
Maria Assunta Rocca

Showing results (51-60 of 1,317) with videos related to

Pageof 132
Sort By:
Journal of the Neurological Sciences|February 1, 2003
MRI-clinical correlations in the primary progressive course of MS: new insights into the disease pathophysiology from the application of magnetization transfer, diffusion tensor, and functional MRIMassimo Filippi
Neuroimaging Clinics of North America|December 10, 2008
Multiple sclerosis, part II: nonconventional MRI techniques. PrefaceMassimo Filippi
Neuroimaging Clinics of North America|December 11, 2008
Multiple sclerosis, Part I: background and conventional MRI. PrefaceMassimo Filippi
Journal of Neurology|April 12, 2014
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatmentMassimo Filippi
The Lancet. Neurology|July 10, 2003
Predictive value of MRI findings in multiple sclerosisMassimo Filippi
Nature Reviews. Neurology|February 8, 2011
Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosisMassimo Filippi
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Journal of Neurology|October 25, 2017
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)Giancarlo Comi, Francesco Patti, Maria Assunta Rocca, et al.
Journal of Neurology|May 13, 2026
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohortMassimo Filippi, Emanuele D'Amico, Vincenzo Brescia Morra, et al.
The Lancet. Neurology|June 14, 2024
Moving towards a connectomic view of neuro-oncologyHugues Duffau, Massimo Filippi
Pageof 132

Showing results (51-60 of 1,317) with videos related to

Sort By:
Pageof 132
Journal of the Neurological Sciences|February 1, 2003
MRI-clinical correlations in the primary progressive course of MS: new insights into the disease pathophysiology from the application of magnetization transfer, diffusion tensor, and functional MRIMassimo Filippi
Neuroimaging Clinics of North America|December 10, 2008
Multiple sclerosis, part II: nonconventional MRI techniques. PrefaceMassimo Filippi
Neuroimaging Clinics of North America|December 11, 2008
Multiple sclerosis, Part I: background and conventional MRI. PrefaceMassimo Filippi
Journal of Neurology|April 12, 2014
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatmentMassimo Filippi
The Lancet. Neurology|July 10, 2003
Predictive value of MRI findings in multiple sclerosisMassimo Filippi
Nature Reviews. Neurology|February 8, 2011
Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosisMassimo Filippi
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Journal of Neurology|October 25, 2017
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)Giancarlo Comi, Francesco Patti, Maria Assunta Rocca, et al.
Journal of Neurology|May 13, 2026
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohortMassimo Filippi, Emanuele D'Amico, Vincenzo Brescia Morra, et al.
The Lancet. Neurology|June 14, 2024
Moving towards a connectomic view of neuro-oncologyHugues Duffau, Massimo Filippi
Pageof 132